Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

I've been writing about software and hardware for PCMag for more than 40 years, focusing on operating systems, office suites, and communication and utility apps. I've specialized in everything related ...

Almost half (48%) of people with multiple sclerosis (MS) have been challenged for using accessible facilities such as disabled toilets, with some being shouted at, harassed or spat on, a survey found.

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...